Moreover, ERU increased the expression of antioxidant target genes, such as GCLC, GCLM and HMOX-1, suggesting that the modulation of ROS production and the impairment of mitochondrial activity in the melanoma cells were among the contributing factors, which supported the antitumor activity of ERU. This evidence concerns the gene GCLM and melanoma.